https://nl.marketscreener.com/koers/aandeel/COGNITION-THERAPEUTICS-IN-127926318/nieuws/Cognition-Therapeutics-Inc-Voltooit-de-inclusie-in-de-Fase-2-SHIMMER-studie-van-CT1812-in-milde-to-46564226/?utm_source=telegram&utm_medium=social&utm_campaign=share